Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications.
about
Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Distribution of Resistant Esop ...... on: Its Clinical Implications.
@ast
Distribution of Resistant Esop ...... on: Its Clinical Implications.
@en
type
label
Distribution of Resistant Esop ...... on: Its Clinical Implications.
@ast
Distribution of Resistant Esop ...... on: Its Clinical Implications.
@en
prefLabel
Distribution of Resistant Esop ...... on: Its Clinical Implications.
@ast
Distribution of Resistant Esop ...... on: Its Clinical Implications.
@en
P2093
P2860
P50
P356
P1433
P1476
Distribution of Resistant Esop ...... on: Its Clinical Implications.
@en
P2093
Brian Weston
David C Rice
Elena Elimova
Graciela M Nogueras-González
Heath D Skinner
Hironori Shiozaki
Jane E Rogers
Jeana L Garris
Jeffrey H Lee
Manoop S Bhutani
P2860
P356
10.1159/000371889
P577
2015-03-05T00:00:00Z